Loading quotes...
Forecast
| Buy |
5 |
| Hold |
3 |
| Sell |
0 |
News Go to news feed
There is currently no news available for this company. We are working on adding more providers to change this.
Financials
| (EUR) | September 2025 | YoY |
|---|---|---|
| Revenue | 171.28k | - |
| Gross profit | 171.28k | - |
| Net profit | -5.09m | - |
| EBITDA | -2.83m | - |
Fundamentals
| Metric | Value |
|---|---|
Market capitalization | €1.92m |
Number of shares | 5.23m |
52-week high/low | €15.26 - €0.28 |
| Dividends | No |
Beta | 1.79 |
P/E ratio | -0.12 |
PEG ratio | 0.00 |
P/B ratio | -0.02 |
P/S ratio | 1.88 |
Company profile
| Name | CLEARSIDE BIOMED. O.N. |
| CEO | George Lasezkay |
| Employees | 32 |
